Heart failure nurse for over ten years with independent prescribing authority. Currently working full-time in Queen's university, undertaking teaching and research. Member of the HFA board 2018-2020. Previous research focused on patients’ and family members’ choice and decision-making at the end-of-life concerning an Implantable Cardioverter Defibrillator. Current projects include European multi-centre study to design and feasibility test an e-Health product (Passion-HF), a co-design study to develop an educational intervention, exploratory study into cardiac cachexia and pilot study on a psychosocial intervention for caregivers of patients with heart failure.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease